| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-14 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-13 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-10 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.26 | 7e-10 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-09 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.25 | 3e-08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.33 | 7e-08 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.33 | 3e-07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |